Medicare Procedure and Patient Information
2014 Medicare Patient Data
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
0 | |
13 |
(No ratings)
Dr. Michelle Lynn Brunnabend, DO, MPH is an obstetrician and gynecologist in Oklahoma City, OK specializing in obstetrics & gynecology. Dr. Michelle Lynn Brunnabend, DO, MPH is affiliated with ASPEN WOMENS CENTER PLLC.
13313 N Meridian Avenue Suite C
Oklahoma City, OK 73120
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Male | 0 |
---|---|
Female | 13 |
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Male | 0 |
---|---|
Female | 40 |
The top procedures that Dr. Michelle Lynn Brunnabend, DO, MPH treated as an obstetrician and gynecologist in Oklahoma City, OK during 2016 were breast exam and gynecologic procedures.
Volume of procedures performed by Dr. Michelle Lynn Brunnabend, DO, MPH for Medicare patients.
breast exam | 10 |
---|---|
gynecologic procedures | 10 |
The most common conditions of Medicare patients that Dr. Michelle Lynn Brunnabend, DO, MPH treated during 2016 were hypertension.
Hypertension | 48 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Male | 0 |
---|---|
Female | 16 |
The most common conditions of Medicare patients that Dr. Michelle Lynn Brunnabend, DO, MPH treated during 2017 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Male | 0 |
---|---|
Female | 16 |
The top procedures that Dr. Michelle Lynn Brunnabend, DO, MPH treated as an obstetrician and gynecologist in Oklahoma City, OK during 2019 were and .
Volume of procedures performed by Dr. Michelle Lynn Brunnabend, DO, MPH for Medicare patients.
doctor visit | 11 |
---|
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Male | 0 |
---|---|
Female | 30 |
From 65 to 74 | 15 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Michelle Lynn Brunnabend, DO, MPH treated during 2019 were hypertension and depression.
Hypertension | 60 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 50 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Male | 0 |
---|---|
Female | 26 |
From 65 to 74 | 15 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Michelle Lynn Brunnabend, DO, MPH treated during 2020 were high cholesterol and hypertension.
Hypertension | 46 |
---|---|
High Cholesterol | 46 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Volume of procedures performed by Dr. Michelle Lynn Brunnabend, DO, MPH for Medicare patients.
The highest averages for the top procedures that Dr. Michelle Lynn Brunnabend, DO, MPH treated as an obstetrician and gynecologist in Oklahoma City, OK were breast exam and gynecologic procedures.
breast exam | 10 |
---|---|
doctor visit | 11 |
gynecologic procedures | 10 |
Information about Medicare patients treated by Dr. Michelle Lynn Brunnabend, DO, MPH.
Female | 14 |
---|---|
Male | 0 |
75 to 84 | 0 |
---|---|
85 and over | 0 |
Less than 65 | 0 |
65 to 74 | 3 |
The highest averages of the most common conditions of Medicare patients that Dr. Michelle Lynn Brunnabend, DO, MPH treated were hypertension, depression and high cholesterol.
Hypertension | 22 |
---|---|
High Cholesterol | 4 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 5 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Atrial Fibrillation | 0 |
Dementia | 0 |
Cancer | 0 |
She has a state license in Oklahoma.
Licensed In: Oklahoma
Dr. Michelle Lynn Brunnabend, DO, MPH is associated with these hospitals and organizations:
Dr. Michelle Lynn Brunnabend, DO, MPH does not have any reviews yet, be the first to leave a review of Dr. Michelle Lynn Brunnabend, DO, MPH here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Michelle Lynn Brunnabend, DO, MPH. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
AbbVie Inc. |
$882
Orilissa $550 |
Liletta $149 |
LO LOESTRIN FE $139 |
ORIAHNN $44 |
||
---|---|---|---|---|---|---|
AbbVie, Inc. |
$419
Orilissa $255 |
Lupron $165 |
||||
HOLOGIC INC |
$394
NovaSure $241 |
Myosure $131 |
Myosure novasure $21 |
|||
Bayer HealthCare Pharmaceuticals Inc. |
$393
Mirena $314 |
Kyleena $47 |
Skyla $16 |
Essure $16 |
||
Duchesnay USA Incorporated |
$357
Diclegis $216 |
Osphena $141 |
||||
Other |
$2,109
IMVEXXY $199 |
INTRAROSA $145 |
ANNOVERA $139 |
ZULRESSO $120 |
ENDOMETRIAL ABLATION SYSTEM $116 |
Other $1,389 |
Food and Beverage | $4,460 |
---|---|
Education | $94 |
Dr. Michelle Brunnabend specializes in general obstetrics & gynecology and practices in Oklahoma City, OK. The average patient rating for Dr. Brunnabend is 4.5 stars (out of 5). She is affiliated with Mercy (Arkansas, Kansas, Missouri, and Oklahoma).